We are currently enrolling for Mosaico (HVTN 706 / HPX 3002):
Mosaico is a global study testing 2 HIV vaccines to see if it protects transgender people and cis-gender men who have sex with men against infection with HIV.
The study will enroll HIV-negative transgender individuals and cis-gender men, age 18 to 60, who have sex with other cis-gender men or transgender people, and have chosen not to use Pre-exposure Prophylaxis (PrEP) to prevent HIV infection.
Participants will receive four injections over the course of a year, assigned to either the vaccines or placebo. Total time in the study will be at least 30 months. Eligible participants receive $75-$125 per study visit and HIV testing and counseling.
